Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder Cancer
Inhibition of the programmed cell death protein-1/ligand-1 (PD-1/PD-L1) axis has opened a new era in the treatment of solid cancers. However, there is no data on the expression and relevance of PD-L1 in Western gallbladder cancer (GBC). We assessed PD-L1 immunohistochemically in 131 GBC patients as...
Main Authors: | Thomas Albrecht, Fritz Brinkmann, Michael Albrecht, Anke S. Lonsdorf, Arianeb Mehrabi, Katrin Hoffmann, Yakup Kulu, Alphonse Charbel, Monika N. Vogel, Christian Rupp, Bruno Köhler, Christoph Springfeld, Peter Schirmacher, Stephanie Roessler, Benjamin Goeppert |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/7/1682 |
Similar Items
-
Low frequency of mismatch repair deficiency in gallbladder cancer
by: Benjamin Goeppert, et al.
Published: (2019-05-01) -
Downregulation of PIM1 regulates glycolysis and suppresses tumor progression in gallbladder cancer
by: Xue C, et al.
Published: (2018-10-01) -
Olaparib Treatment in a Patient with Advanced Gallbladder Cancer Harboring BRCA1 Mutation
by: Li X, et al.
Published: (2021-04-01) -
Intrahepatic Gallbladder
by: Sherif Monib, et al.
Published: (2019-05-01) -
Immunoproteomics approach revealed elevated autoantibody levels against ANXA1 in early stage gallbladder carcinoma
by: Javed Akhtar, et al.
Published: (2020-12-01)